Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevation Oncology Inc (NQ: ELEV )

3.710 -0.170 (-4.38%)
Streaming Delayed Price Updated: 10:11 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 127,880
Open 3.890
Bid (Size) 3.700 (6)
Ask (Size) 3.720 (1)
Prev. Close 3.880
Today's Range 3.620 - 3.920
52wk Range 0.3630 - 5.890
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Top Stocks Under $7
Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now. 
Via InvestorPlace
5 Healthcare Stocks to Buy for 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+489.83%
+489.83%
1 Month
-19.00%
-19.00%
3 Month
+49.90%
+49.90%
6 Month
+529.67%
+529.67%
1 Year
+116.96%
+116.96%

More News

Read More
ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023
Via InvestorPlace
Recap: Elevation Oncology Q4 Earnings
Via Benzinga
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
Via InvestorPlace
How Is The Market Feeling About Elevation Oncology?
Via Benzinga
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL
Via AB Newswire
3 Stock Winners That Are Up 400% or More in 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Via FinancialNewsMedia
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
What's Going On With Elevation Oncology Stock?
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
From FN Media Group LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
Crude Oil Down Over 1%; Planet Labs PBC Shares Tumble
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Edges Lower; Sientra Shares Spike Higher
Via Benzinga
Why Elevation Oncology (ELEV) Stock Is Getting Obliterated
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.